ClinicalTrials.gg
RecruitingNCT07754071Updated Aug 10, 2026

Clinical Validation of an Artificial Intelligence System for De-termining Fetal Lie and Position in 3rd Trimester

An observational study in Pregnancy, Fetal Presentation and Breech Fetal Presentation, sponsored by Copenhagen Academy for Medical Education and Simulation. Recruiting at 3 sites in Denmark. Open to female participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2026-08-10.

Sponsored by Copenhagen Academy for Medical Education and Simulation · Observational

From the registry’s dates

  • Started Sep 2025; still recruiting 1 year 2 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
150
Ages
18 Years to 70 Years
Sex
Female
01

Study summary

This prospective clinical validation study aims to evaluate the diagnostic performance of an artificial intelligence (AI)-based navigational support system for determining fetal lie and presentation during third-trimester ultrasound examinations. Following routine clinical assessment by an expert clinician, three blind ultrasound sweeps will be obtained from each participant. The AI system will generate predictions of fetal lie and presentation from each sweep, which will be compared with the expert clinician's assessment as the reference standard. The study will also explore clinician perceptions of the system's usability and potential clinical value.

Read the detailed description

Accurate assessment of fetal lie and presentation during the third trimester is essential for obstetric management and delivery planning. Ultrasound is the gold standard for determining fetal orientation; however, the examination is highly operator-dependent and requires considerable experience to correctly identify fetal anatomy and orientation. Artificial intelligence (AI)-based navigational support systems have the potential to assist clinicians by providing real-time guidance during ultrasound examinations and improving the consistency of fetal orientation assessment.

The purpose of this study is to prospectively validate an AI-based navigational support system for determining fetal lie and presentation during routine third-trimester ultrasound examinations. The system analyzes blind ultrasound sweeps acquired along the maternal midline and automatically predicts fetal lie and presentation. AI-generated predictions will be compared with expert clinician assessment, which serves as the reference standard.

Eligible pregnant women attending third-trimester ultrasound examinations at the Fetal Medicine Department, Rigshospitalet, Slagelse - or Hillerød hospital, will be invited to participate. Following written informed consent, an expert clinician will first determine fetal lie and presentation as part of the routine ultrasound examination. The same clinician will subsequently acquire three blind ultrasound sweeps along the maternal midline. The AI navigational support system will analyze each sweep and generate predictions of fetal lie and presentation. All examinations will be completed within 5-10 minutes to minimize changes in fetal orientation between the clinical assessment and AI evaluation.

The primary objective is to evaluate the diagnostic performance of the AI system by comparing AI-generated predictions with expert clinician assessment. Primary outcome measures include overall diagnostic accuracy and agreement,

These findings will provide additional insight into the feasibility of implementing AI-assisted navigational support in routine obstetric ultrasound practice.

02

Conditions studied

  • Pregnancy
  • Fetal Presentation
  • Breech Fetal Presentation
  • Cephalic Fetal Presentation

Browse trials for

Keywords

  • fetal lie
  • fetal presentation
  • obstetric ultrasound
  • artificial intelligence
  • AI-assisted ultrasound
  • Navigation system
  • blind ultrasound sweep
  • third trimester pregnancy
  • clinical validation
  • Diagnostic accuracy
  • fetal orientation
03

In context

Breech Presentation

41 studies on the registry are indexed under Breech Presentation; 10 are open to participants now.

This study's planned enrollment of 150 is above the median of 135 across 10 observational studies indexed under Breech Presentation.

Browse Breech Presentation studies →

Lead sponsor

Copenhagen Academy for Medical Education and Simulation is the lead sponsor of 27 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Pregnant women with singleton pregnancies attending third-trimester ultrasound examinations at the Fetal Medicine Department, Rigshospitalet, Slagelse Hospital, or Hillerød Hospital.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Pregnant women aged ≥18 years.
  • Singleton pregnancy.
  • Gestational age ≥28+0 weeks.
  • Fetus in longitudinal lie (cephalic or breech presentation) as determined by the routine clinical ultrasound examination.
  • Able to understand Danish or English.
  • Able and willing to provide written .

Exclusion criteria

Exclusion Criteria:

  • Multiple pregnancy.
  • Fetus in transverse lie.
  • Inability to provide written .
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
150 participants (estimated)
Patient registry
No

Groups and cohorts

  • Prospective Clinical Validation Cohort

    Pregnant women with singleton pregnancies in the third trimester (≥28+0 weeks' gestation) undergoing obstetric ultrasound examination. Participants undergo three blind ultrasound sweeps, and AI-generated predictions of fetal lie and presentation are compared with expert clinician assessment.

06

What researchers measure

Primary outcomes

  1. Diagnostic accuracy of the AI navigational support system for determining fetal lie and presentation.

    Overall proportion of correct AI predictions of fetal lie and presentation compared with expert clinician assessment (reference standard).

    Time frame: During the study ultrasound examination (approximately 5 minutes).

Secondary outcomes

  1. Agreement between AI predictions and expert clinician assessment.

    Agreement will be evaluated using Cohen's kappa coefficient.

    Time frame: During the study ultrasound examination.

07

Study locations

1 of 3 sites recruiting
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be made publicly available because the dataset contains identifiable medical imaging data and is subject to Danish data protection regulations (GDPR).

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 10, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07754071
Lead sponsor
Copenhagen Academy for Medical Education and Simulation
Responsible party
Mary Le Ngo (Medical doctor, Copenhagen Academy for Medical Education and Simulation) — Principal investigator
First posted
Aug 10, 2026
Start date
Sep 11, 2025
Primary completion
Oct 1, 2026 (estimated)
Completion
Oct 1, 2026 (estimated)
Last update
Aug 10, 2026

Study contacts

Mary Le Ngo, MD, MD
Contact
mary.van.anh.le.ngo.01@regionh.dk
+45 20773779

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion